ArticlePLoS computational biology2026
Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumor development and progression are affected not only by cancer cell-intrinsic factors comprising complex genetic variations, but also by -extrinsic factors such as cell-cell communication (CCC)-mediated immunosuppression. However, whether and how these two types of factors influence each other remains an open question. We present Driver2Comm, a general computational framework designed to systematically identify intrinsic-extrinsic (IE) pathways that functionally connect cancer cell driver genes with their associated CCC signatures in the tumor microenvironment (TME). By applying Driver2Comm to single-cell and spatial transcriptomic datasets of multiple cancer types, we find that driver gene-associated CCC signatures play critical roles in immune regulation, metastasis, and therapy response. These signatures not only illuminate mechanisms of TME remodeling but also demonstrate clinical value in predicting patient survival and response to immune checkpoint blockade. Furthermore, Driver2Comm captures higher-order, cell-type-pair-specific CCC functional modules and spatially coherent CCC patterns in tissue contexts. As a generalizable tool, Driver2Comm bridges cancer genomics and cellular ecosystems, offering insights into biomarker discovery and combination therapy strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.